Post My Press Release

Free Press Release Distribution

Author: adpande@yandex.com (Page 1 of 7)

Internet of Things IoT in Healthcare Market Estimated to Flourish by 2025

According to a new market report published by Transparency Market Research, the global IoT in healthcare market is expected to reach US$ 322.77 Bn by 2025, expanding at a CAGR of 20.6% from 2017 to 2025. North America held the highest market share in the IoT in healthcare market in 2016. According to the report, the global IoT in healthcare market will continue to be influenced by a range of macro economic and industry-specific factors.

Internet connected devices have been introduced to monitor and diagnose patients in various ways. Tracking health information is vital for patients whether the data comes from electrocardiograms, fetal monitors, blood glucose levels, or temperature monitors. Most of these measures require follow-up with healthcare professionals, creating an opportunity for smarter electronic devices to deliver more valuable data by reducing the need for direct physician-patient interaction.

Most hospitals have started installing ‘smart beds’ enabling them to detect when the patient is attempting to get up and when it is occupied. It can also self-adjust to ensure that the appropriate support and pressure is applied to the patient without manual intervention. Another benefit of IoT in healthcare is integration with home medical dispensers to automatically upload data on cloud when medication is not taken or in any other case which requires the health professional to be alerted.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11975

The report offers detailed segmentation based on component, application, end-use, technology, and region. Based on component, the market is segmented into hardware, software, and services. The hardware component has been further classified into portable diagnostic devices and non-portable diagnostic devices. Portable diagnostic devices are further segmented into on-body wearable and others. By application, the market is segmented into telemedicine, medication management, clinical operations, patient monitoring, connected imaging and others. By end-use, the market is classified into hospitals, pharmaceuticals, and clinics & laboratories. In terms of technology, the IoT in healthcare market has been segmented into Bluetooth, Wi-Fi, NFC, Zigbee, RFID, and others which include cellular, satellite, Zwave, and EnOcean.

Key industry participants of the IoT in healthcare market are AdhereTech Inc., Cerner Corporation, IBM Corporation, Qualcomm Technologies Inc., Cisco Inc., General Electric Company, Ericsson AB, Honeywell International, Medtronic Inc., SAP SE, Vodafone, and Zebra Technologies. Players indulge in mergers and acquisitions, new product launches, and follow forward and backward integration strategies to remain globally competitive.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11975

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Nurse Call Systems Market to Expand with Significant CAGR by 2025

The global nurse call systems market is expected to experience a significant growth in future years owing to rise in old age people all across the globe. According to analysis of the market opportunity, the global nurse call systems market is exceedingly focused and broadened because of the emergence of several large and small organizations. Likewise, to build their market size and market shares, these vendors are creating nurse call systems with integrated wired technology or wired technology. Additionally, the vendors go against each other owing to various factors, for example, product differentiation, aggressive pricing, capital support for product or technology upgrades, and distribution partnerships to improve their position in the market. Cornell Communications, Azure Healthcare Ltd., Hill-Rom Holdings, Inc., TekTone Sound & Signal Mfg., Inc., Ascom Holding AG, Tyco SimplexGrinnell, Rauland-Borg Corporation, STANLEY Healthcare, Jeron Electronic Systems, Inc., and Vigil Health Solutions, Inc. are among the key players leading the global nurse call systems market.

According to a report by Transparency Market Research (TMR), the demand in the global nurse call systems market is anticipated to grow at a noteworthy CAGR of 10.9%within the forecast period from 2017 to 2025, evaluating it to achieve a valuation of US$2,665.98 mn by the end of 2025. The majority of the leading players are depending on recent innovations with a specific end goal to separate themselves from the competitors and lead in market share. The report additionally expects offering of customized facilities as indicated by the necessities of particular hospital, acquisitions of promising players, new product launch, and notable contract wins as some more alternate methodologies of the key players to grow their revenue in the market. The IP-based nurse call systems market held the maximum shares due to highest demand, in 2016. The segment led the others owing to its property of flexibility while installation. Additionally, the demand for the segment is anticipated to keep on growing within the forecast period as well. Azure healthcare Ltd. got an order of worth US$1.1 mn from healthcare center in North America, in August 2016 for IP-based nurse call systems ‘Tacera’. Geographically, North America region led the market in 2016, because of rise in geriatric population and assisted healthcare homes. This region is expected to sustain its leading position in coming years as well.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2173

Rise in healthcare expenses, particularly in the developed nations, increasing popularity of medical insurance in various developing economies, prevalence of chronic infections, increase in old age population over the world, increased investment in healthcare industry, technological headways and product upgradation, government bolster for advanced innovation that helps in consumers’ care progressively, and convenient availability of information for essential healthcare departments are a some of the essential drivers propelling the global nurse call systems market.

Upcoming technologies, for example, integration of nurse call systems with cell phones and in-in-hospital remote telephones, centralized nurse call system, interoperable designs, and expanding nurse contribution in healthcare sector are among the major reasons that are anticipated to surge up the global growth of nurse call systems market.

Then again, factors, for example, increased expenses of implementation, challenges relating to interoperability and integration, strict government regulations, and the lack of skilled professionals who can work productively with IT and healthcare are obstructing the market for nurse call systems from accomplishing its actual potential.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2173

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Digital Pathology Market to Witness Exponential Growth by 2026

Transparency Market Research (TMR) has published a new report titled, “Digital Pathology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global digital pathology market was valued at US$ 340 Mn in 2017, and it is projected to expand at a CAGR of more than 12% from 2018 to 2026. Increase in installation of digital systems and workload of pathologists is projected to drive the global market during the forecast period. North America and Europe are anticipated to dominate the global digital pathology market in the next few years owing to the rise in prevalence of cancer, improvement in technology, and increase in elderly population in these regions. The digital pathology market in Asia Pacific is expected to expand at a rapid pace from 2018 to 2026. This is attributed to the increase in prevalence of cancer and rise in awareness about healthcare IT and its application in developed countries such as Japan and Australia. The market in Asia Pacific is projected to expand at a CAGR of more than 13% from 2018 to 2026.

High prevalence of cancer and accurate pathological assessment and digitalization are major factors that are projected to fuel the global digital pathology market during the forecast period. Decrease in number of pathologists in countries such as the U.S., leading to ever increasing workload, is an important factor that is likely to drive the global market during the forecast period. Furthermore, advancements in diagnostic tests, rise in number of clinical and preclinical trials, rise in in automation, and improvement in healthcare infrastructure are key factors driving the global market. However, high cost of initial set up, sampling errors, and stringent regulatory requirements are some factors that are likely to restrain the market during the forecast period.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1540

The report offers detailed segmentation of the global digital pathology market based on product type, end-user, application, and region. In terms of product type, the digital pathology market has been classified into image analysis software and scanners. The image analysis software segment is expected to account for a leading share of the global market during the forecast period. Higher share held by the segment is attributed to improved technology and ease of usage of the software. Based on end-user, the global market has been segregated into diagnostic laboratories, academic & research centers, pharmaceutical companies, and others. The diagnostic laboratories segment dominated the global market, accounting for more than 30% share in 2017 due to the rise in prevalence of infectious diseases and chronic diseases such as cancer. Based on application, the global digital market has been split into diagnosis, consulting services, educational, and others. The educational segment is expected to expand at a prominent CAGR during the forecast period due increase in research activities, globally.

In terms of region, the global digital pathology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a major share of the global market, in terms of value, in 2017. It is projected to dominate the market during the forecast period. The market in the region is anticipated to expand at a CAGR of more than 12% from 2018 to 2026. Rise in awareness about healthcare IT applications, shortage of pathologists, and easy usage of the systems are likely to drive the market in the region during the forecast period. Europe is projected to account for the second-largest share of the global digital pathology market by 2026. The market in the region is anticipated to expand at a significant CAGR from 2018 to 2026. Rise in geriatric population and high health care spending are expected to fuel the market during the forecast period.

The digital pathology market in Asia Pacific is anticipated to expand at a rapid pace from 2018 to 2026. The market in the region is likely to expand at a CAGR of more than 13% during the forecast period. Increase in population, rise in prevalence of cancer, increase in awareness towards digital pathology systems, and rise in government initiatives toward diagnosis of diseases are expected to boost the market in the region. Australia, Japan, India, and China are potential markets for digital pathology in Asia Pacific. The market in China is expected to expand rapidly at a notable CAGR during the forecast period due to rise in population, inexpensive digital systems, and high installed based. The digital pathology market in Latin America is projected to expand at a CAGR of more than 11% from 2018 to 2026. Investment by major players is anticipated to propel the market in the region.

Key players in the global market are adopting strategies such as mergers and acquisitions, technological developments, and geographic expansion in order to capture significant market position. Major players operating in the global digital pathology market include Leica Biosystems Imaging, Inc, OLYMPUS CORPORATION, F. Hoffmann-La Roche Ltd, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, and Inspirata.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1540

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Gastrointestinal Drugs Market to Develop Rapidly by 2024

The global gastrointestinal drugs market is predicted to witness a steady growth in the coming years, as analyzed by a recent Transparency Market Research (TMR) report. The vendor landscape of the global market features consolidation, with leading three players accounting for a significant share in the market collectively. The top three vendors in the market, viz. Janssen Biotech Inc., Takeda Pharmaceutical, and Valeant Pharmaceuticals Inc. hold over 60% of the total market share at present. Established vendors have deployed strategies such as enhancement of distribution channels, novel product development, and expansion to regional markets.

Vendors are also seen focusing on efficient supply chain management and procurement of the drugs, thereby increasing their operational efficiency. This is one of the top strategies that leading vendors have adopted in order to gain momentum in the global gastrointestinal drugs market. Recently, Allergan Inc divested its genetic branch by selling off Anda, Inc., to Teva Pharmaceuticals. This has resulted in Allergan focusing more on key therapeutic areas, and enhance their branding.

Other prominent vendors operating in the global gastrointestinal drugs market are Sanofi, Astra Zeneca, Abott Laboratories, Bayer AG, and Allergen Plc.

According to TMR analysts, the global gastrointestinal drugs market is projected to rise at a 4.90% CAGR over the forecast timeframe of 2016 to 2024. The market was estimated to hold a revenue of US$45.5 bn in 2015, which is foretold to reach US$61.6 bn by 2024.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20987

Expanding interests in research activities for the improvement of these drugs and the developing mindfulness about the accessibility of the medications are likewise adding considerably to the development of this market. The surge in awareness about the malady and the expanding accessibility of treatment choices is boosting the growth of the gastrointestinal drugs market. Likewise, the innovative headways in the treatment technology are expected to help the market gain traction. Rising number of patients experiencing GI issues, attributable to adjust in the dietary lifestyles, additionally emphatically influences the development of the gastrointestinal drugs market. The high unmet need and interest for better medications and the high commonness of stomach related conditions make the gastrointestinal market an alluring contender for remedial advancement.

Moreover, activities initiated by associations, for example, the Centers for Disease Control and Prevention (CDC) that advance tumor screening over the globe are expected to support market development over the forthcoming years. This expansion in activities for screening is required to fuel offers of therapeutics and present lucrative potential to the market vendors.

Branded drugmakers and generic drug firms are working together to create conventional drugs after patent expiry, or, in other words, support the development of generics. Likewise, companies are progressively concentrating on creating generics attributable to increment in off-protected drugs in the market. The generic type of segment of drugs is expected to rise at an exponential rate attributable to steady expiries of licenses, cost-viability of generics, and activities by government associations for advancing utilization of generics in developing countries. Likewise, significant pharmaceutical organizations are reliably endeavoring to dispatch generic adaptations of their branded counterparts.

As the number of doctor-prescribed drugs being insured for is rising, it is urging patients to buy medications from retail drug stores. These factors are expected to support client tendency toward retail locations. On the off chance that retail drug specialists have any worries with respect to endorsed meds, they suggest options for the equivalent, accordingly guaranteeing higher security.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20987

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Urolithiasis Management Devices Market to be at Forefront by 2024

The global urolithiasis management devices market has a highly competitive vendor landscape, observes Transparency Market Research (TMR). Companies such as Boston Scientific Corporation, C. R. Bard, Inc., and Cook Group command prominent positions in the global market owing to their strong geographic presence, excellent distribution networks, and the financial power to acquire niche device developers across the globe. The degree of competition is high in the maturing market, with frequent changes to the development dynamics owing to rapid advancements in supporting technologies. Despite the presence of a large number of regional players, the global market for urolithiasis management devices is dominated by few large vendors having substantial budgets for research and development of new technologies and innovative products, observes TMR in a recent report.

Transparency Market Research estimates that the global urolithiasis management devices market will expand at a healthy 4.5% CAGR over the period between 2016 and 2024. The market’s worth is estimated to be US$1.26 bn in 2016 and is expected to rise to US$1.78 bn by 2024. North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Based on the end user, segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252

The market for urolithiasis management devices is primarily driven owing to the rising prevalence of kidney stones among the global population. Factors such as obesity, changing lifestyles, and ageing are the chief causes triggering the formation of kidney stones among humans. Studies state that at least 30% of the world’s population is presently obese or overweight. Geriatrics (people with more than 60 years of age) account for more than 900 mn people of the world’s population presently. The United Nations’ Department of Economic and Social Affairs states that this number will increase by 56% between 2015 and 2030 and rise to 1.4 bn by 2030.

Along with these factors, the introduction of a variety of non-invasive treatment methods in the global urolithiasis management devices market has also encouraged the excellent growth of the market in the past few years. The significant reduction in treatment duration and effective results are compelling an increased number of patients to demand newer and technologically advanced treatment methods for kidney stones.

Certain urolithiasis procedures such as the lithotripsy involve shockwaves that are sent across the body to trigger kidney stones with high precision force. Such treatments may result in damage to soft tissues and could also potentially lead to a permanent loss of renal functions. This factor leads to increased concerns among patient about the potential side-effects of novel technologies and hampers the overall adoption of urolithiasis management devices to a notable extent. Another key challenge for the global urolithiasis management devices is the high cost of certain latest and novel technologies, which restrains market’s growth across developing economies to a large extent.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2252

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Single-Cell Analysis Market to Register a Stout Growth by End 2025

The global single-cell analysis market is highly consolidated in nature. Major players in the market holds the significant share in market, reports Transparency Market Research in a newly published report. In order to outrun each other, top players in the market are relying on innovation and development. Players are focusing extensively on production of new products to attract more consumers in the single-cell analysis market. Partnerships and collaborations with regional and other players in the market are also likely to help the global players to gain traction in other pockets of the region. Some of the major players in the market are Thermo Fisher Scientific Inc., Eppendorf AG, Becton, Dickinson and Company, 10x Genomics, Bio-Rad Laboratories Inc., Illumina Inc., and NuGEN Technologies.

According to TMR, the global single-cell analysis market is anticipated to expand at a robust CAGR of 15.4% during the assessed period, 2017 – 2025 on the basis of revenue. At this rate, the global single-cell analysis market will reach a market valuation of US$6.5 bn by the end of the forecast period. The market on the basis of product type is bifurcated into consumables and instruments. Of these, consumables are anticipated to hold a dominant share during the assessed period. On the basis of geography, the market is North America holds a lion’s share owing to rise in funding for improved infrastructure, research, incessant rise in cancer cases, and increasing awareness among consumers. Riding on these factors, North America is anticipated to exhibit a stellar CAGR in the coming years.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10565

Rapid Advancement in the healthcare sector all across the world is helping the market to grow stupendously. The healthcare industry in countries such as China, India, and Japan is likely to thrive in the coming years due to prevalence of various chronic disorders all across the world. This is anticipated to bolster the demand in the global single-cells analysis market. Government in various emerging countries such as India and China are investing in research activities in order to bring new developed and advancement treatment for various diseases. This is anticipated to favor the growth of the market during the forecast period. Significant rise in healthcare expenditure is also expected to augment the growth of the market.

Heavy investments in research and development from government is considered as one of the primary driver of the market. Research on single-cell analysis is considered to be exorbitant, and apart from major players, new and small players are unable to bear such exorbitant expenses. Aid from government end is likely to make the market flourish. Except this, partnerships and collaboration among major players to produce new platforms for single-cell analysis is anticipated to augment the market growth. Several players in the Asia Pacific region are known to sign in distribution agreement to satisfy demand in various pockets of a region.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10565

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Ultrasound Devices Market: Global Forecast Over 2026

Transparency Market Research (TMR) has published a new report titled, “Ultrasound Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global ultrasound devices market was valued at US$ 6.5 Bn in 2017. It is projected to expand at a CAGR of 5.6% from 2018 to 2026. Surge in incidence of various disorders such as cardiovascular diseases, respiratory, and abdominal disorders cases is anticipated to boost the demand for ultrasound devices during the forecast period. North America and Europe are projected to dominate the global ultrasound devices market owing to higher rate of adoption and awareness regarding ultrasound devices. Asia Pacific, Latin America, and Middle East & Africa are potential markets for ultrasound devices. The market in Asia Pacific is expected to expand at a CAGR of 6.2% from 2018 to 2026.

Increase in number of cases of various disorders, across the globe, drives the ultrasound devices market. According to the WHO, cardiovascular diseases accounted for an estimated 17.7 million deaths in 2015, representing 31% of all global deaths. Among these, an estimated 7.4 million were due to coronary heart disease, and 6.7 million were due to stroke. This is likely to increase the number of diagnostic procedures; consequently, propelling the global ultrasound devices market.

Compact/handheld ultrasound devices is an emerging segment of the ultrasound devices market. The compact/handheld ultrasound devices segment is likely to expand at a significant CAGR. Moreover, the trolley/cart-based ultrasound devices segment is likely to hold a major share due to technologically advanced product adopted by diagnostic centers. Moreover, increased adoption of portable ultrasound devices for point-of-care applications, it cannot outpace the trolley/cart based ultrasound devices, as they offer more accurate diagnostic capabilities and high performance.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2483

In terms of application, the global ultrasound devices market has been segmented into various applications. Radiology/general imaging is projected to be a highly attractive segment during the forecast period. Rising sophistication in diagnostic imaging platform, which enables emerging countries to provide 24X7 diagnostic services to its clients is likely to propel this segment during the forecast period.

In terms of end-user, the global ultrasound devices market has been segregated into hospital & surgical centers, diagnostic centers, ambulatory surgical centers, and others. The diagnostic centers segment held a major share of the global market in 2017. Expansion of the segment can be attributed to the availability of multiple service options and devices and tie-ups with health care companies in order to enhance health care products and service offerings. Moreover, diagnostic centers are the preferred choice due to availability of advanced technology and better health care services. The hospital & surgical centers segment is expanding at a high growth rate, especially in developed economies, due to rise in geriatric population and increasing health care infrastructure and support. Moreover, rise in demand for ultrasound devices in ambulatory surgical centers during medical emergency is projected to drive the segment.

In terms of region, the global ultrasound devices market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global ultrasound devices market in 2017. In terms of revenue, the market in Europe was valued at US$ 2.1 Bn in 2017, owing to a highly developed health care sector, increase in awareness among health care providers about ultrasound devices, and continuous evolution of ultrasound devices. This region offers significant opportunity to the ultrasound devices market. The ultrasound devices market in Asia Pacific is anticipated to expand at a CAGR of 6.2% during the forecast period, due to increase in awareness about ultrasound devices for diagnostic and therapeutic. Moreover, expansion of the health care sector in countries such as China, Japan, and India offers immense potential in this region. Additionally, technological advancements and increase in rate of adoption of ultrasound devices products are expected to propel the market in the region during the forecast period.

The global ultrasound devices market is highly fragmented in terms of number of players providing different products. Key players in the global ultrasound devices market include GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi, Ltd., Siemens Healthineers, Mindray Medical International Limited, Samsung Medison Co., Ltd., Fujifilm Holdings Corporation, Esaote SpA, and Analogic Corporation. Expansion of product portfolio through mergers and acquisitions is a key strategy followed by several global players.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2483

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Tissue Diagnostic Market Set to Record Exponential Growth by 2024

In a recent report by Transparency Market Research (TMR), the global tissue diagnostics market is anticipated to gain a remarkable boost across the globe. This is mainly because of the rising prevalence of cancer. Another important factor responsible for boosting the global tissue diagnostic market is infrastructure development of healthcare and medical industry. Only new players with potential and expertise can exist in the market.

Some of the leading players in the global tissue diagnostic market are Roche Diagnostics, Thermo Fisher Scientific Inc., Agilent Technologies, 3DHISTECH, and Becton Dickinson & Co. These companies are substantially focused on mergers and acquisitions for sustaining their dominance in the market.

As per the TMR report, the global tissue diagnostic market is estimated to exhibit a 9.50% CAGR within the forecast period of 2016 to 2024. The value is presumed to be valued at US$8.02 bn by the end of the forecast period.

Request to View Sample of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19607

The global tissue diagnostic market is driven mainly because of the rising cases of cancer all over the world. It is assumed that on a global scale, one out of six deaths is due to cancer. This turns out to be a powerful factor increasing the growth for tissue diagnostic market globally. Apart from cancer cases, the growing number of geriatric population may also increase the demand for world tissue diagnostic market since elderly people are highly vulnerable to diseases and require medical care almost on a regular basis.

With the rising need for better treatment of cancer patients, the improvement in healthcare infrastructure has been noticeable. This may have a positive impact the tissue diagnostic market at a global level. Devices used for detecting cancer like computer-aided diagnostics (CAD) systems and imaging technology are also foreseen to positively influence the tissue diagnostics market.

An important factor that may restrict the growth of the tissue diagnostic market is delay in introduction of new treatment, and unfavorable reimbursement. Delayed approvals for new methods of treatment and other potential tests by the Food and Drug Administration (FDA) restricts growth. Apart from this, cost of healthcare essentials like diagnostic tests and high treatment charges are also anticipated to hamper the development of the tissue diagnostic market. Usually FDA approvals takes more time than usual, and may also attracts massive expense.

Despite delayed approvals and high cost expenses, rise in mergers and acquisitions, innovation, growing awareness, economic development and increasing disposable income are major factors leading to the expansion of the market. There is an increase in awareness about tissue diagnostic in developing countries. Apart from that, rising trend of both quantitative and qualitative tissue sample analyses along with targeted specific antibody discoveries in biopharmaceutical industries are expected to boost the global tissue diagnostic market.

Request to View Brochure of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19607

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Page 1 of 7

Powered by WordPress & Theme by Anders Norén